In a close 7-6 vote, a committee of medical experts said today that eteplirsen, a drug to treat Duchenne muscular dystrophy, has not met the bar set by the FDA for approval, which could make the drug the third Duchenne treatment... Read more »
Last week, New York-based Apester, a platform brands and publishers can use to tell stories with digital content, announced it closed a $17 million Series A round led by Blumberg Capital.
Finding new ways to hold the audience’s attention with digital... Read more »
Purdue University, which prides itself on teaching innovation, is joining with a financial technology startup in an unusual partnership that may pave the way for lower-cost tuition payment options for students at other higher education institutions some day.
Starting May 2,... Read more »
It doesn’t seem to matter where you live, what you do, or what industry your company is in—the likelihood of a cyber attack is growing, and protecting yourself is ever more front of mind.
Xconomy’s editors around the United States have... Read more »
It’s too early to call it a breakthrough, but for the first time, a gene therapy has been shown to have a real impact on patients with hemophilia A, the most common form of the chronic blood disease. The early data,... Read more »
Cerebral adrenoleukodystrophy is a rare, crippling neurological disease that leaves its patients, typically boys, severely disabled and ultimately dead in a matter of years. Only painful, dangerous bone marrow transplants can stop the progression of CALD. But while the transplants are... Read more »
By 2029, more than 20 percent of people in the United States will be over the age of 65. That’s why the race to find effective treatments for Alzheimer’s disease feels urgent. A few drugs, approved well over a decade ago,... Read more »
It’s four weeks until Napa Summit 2016: The Xconomy Retreat on the Economy, Jobs, and Growth. We have now posted the agenda, and we’d love to see you there. So request your invitation today to Xconomy’s most prestigious event.
The... Read more »
A bit of new technology has emerged from a partnership between AOL and New York-based Cornell Tech.
Last week, AOL and the Jacobs Technion-Cornell Institute at Cornell Tech announced in a press statement they had come up with something called immersive recommendations... Read more »